Cargando…
Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474649/ http://dx.doi.org/10.1186/2047-2994-4-S1-I2 |
_version_ | 1782377310363582464 |
---|---|
author | Singh, UP Srivastava, JK Bhat, HR |
author_facet | Singh, UP Srivastava, JK Bhat, HR |
author_sort | Singh, UP |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4474649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44746492015-06-25 Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate Singh, UP Srivastava, JK Bhat, HR Antimicrob Resist Infect Control Innovation Academy Presentation BioMed Central 2015-06-16 /pmc/articles/PMC4474649/ http://dx.doi.org/10.1186/2047-2994-4-S1-I2 Text en Copyright © 2015 Singh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Innovation Academy Presentation Singh, UP Srivastava, JK Bhat, HR Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title | Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title_full | Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title_fullStr | Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title_full_unstemmed | Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title_short | Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
title_sort | structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate |
topic | Innovation Academy Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474649/ http://dx.doi.org/10.1186/2047-2994-4-S1-I2 |
work_keys_str_mv | AT singhup structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate AT srivastavajk structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate AT bhathr structurebasedoptimizationanddiscoveryofnovel135triazinederivativesasbacterialtranslationinhibitorwithfavourablemetabolicfate |